Healthcare & Biotechnology 

We have been overweight in healthcare and biotechnology for over a decade, as we continue to see opportunities in both public and private markets. We invest directly in early to late-stage companies, in addition to comingled alternative funds. Currently, we are pursing opportunities, both public and private, in the arenas of brain health and well-being. 

William Woods, MD, Senior Healthcare Advisor

William Woods joined the Cooper Family Office with over 28 years’ experience as a leading board-certified radiation oncologist, as well as that of a seasoned individual investor. Educated at Princeton University (honors), Columbia University and Albert Einstein College of Medicine, he brings his extensive medical expertise to explore oncologic and other cutting-edge biomedical investment opportunities. Dr. Woods is a member of the Johns Hopkins University Discovery Council. He oversees investments in healthcare, biotechnology, medical technology and medical devices for the team.

Roxanna Namavar, DO, Senior Biotechnology Advisor

Roxanna Namavar, DO, joined the Cooper Family Office as a physician and Board-Certified psychiatrist, and a Fellow in the American Academy of Anti-Aging. She completed her residency at the University of Virginia Health-System. In her New York practice, Dr. Namavar was dedicated to cutting-edge medical therapies focused on the intersection of functional medicine, cellular regeneration and anti-aging to promote longevity. Dr. Namavar oversees due diligence in companies specializing in novel, scientifically-backed processes and devices. She is active in portfolio investments in healthcare, biotechnology hedge funds, and private equity. Dr. Namavar focuses on evaluating early and latter-stage companies and venture capital in the healthcare arena on behalf of the family office. 

Sofia Sakopoulos, Healthcare & Biotechnology Analyst

Sofia Sakopoulos joined the Cooper Family Office as a healthcare and biotechnology analyst for the Team’s physicians.  She received her B.S. in Behavioral Neuroscience from Northeastern University and is pursuing an M.A. in Clinical Psychology with a concentration in Mental Health and Substance Abuse Counseling at The New School for Social Research. Ms. Sakopoulos has had extensive molecular neuroscience research experience with the Stanley Center for Psychiatric Research at the Broad Institute of MIT & Harvard. Her interests include integrating cutting-edge pharmacological science and psychological interventions for an effective understanding of treatment interventions for brain circuitry and neural mechanisms associated with advanced psychopathologies. She is actively involved in philanthropic endeavors, volunteering her time to coach tennis to underprivileged children living in the projects in Brooklyn, New York.